tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Income Statement

Compare
219 Followers

Vivos Therapeutics Income Statement

Last quarter (Q3 2025), Vivos Therapeutics's total revenue was $6.78M, an increase of 75.73% from the same quarter last year. In Q3, Vivos Therapeutics's net income was $-5.40M. See Vivos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 15.03M$ 13.80M$ 16.02M$ 16.89M$ 13.07M
Gross Profit
$ 9.02M$ 8.27M$ 10.02M$ 12.60M$ 10.41M
Operating Expenses
$ 20.19M$ 25.57M$ 35.05M$ 32.08M$ 19.12M
Depreciation and Amortization
$ 581.00K$ 621.00K$ 669.00K$ 733.00K$ 717.87K
EBITDA
$ -10.55M$ -16.68M$ -24.36M$ -19.54M$ -11.24M
Operating Income
$ -11.17M$ -17.30M$ -25.03M$ -19.47M$ -8.71M
Other Income/Expenses
$ 35.00K$ 3.71M$ 1.19M$ 94.00K$ -3.35M
Pretax Income
$ -11.14M$ -13.58M$ -23.84M$ -20.29M$ -12.06M
Net Income
$ -11.14M$ -13.58M$ -23.84M$ -20.29M$ -12.06M
Per Share Metrics
Basic EPS
$ -2.22$ -11.14$ -25.90$ -23.89$ -24.70
Diluted EPS
$ -2.22$ -11.14$ -25.90$ -23.89$ -24.70
Weighted Average Shares Outstanding
5.02M 1.22M 920.48K 849.32K 728.38K
Weighted Average Shares Outstanding (Diluted)
5.02M 1.22M 920.48K 849.32K 728.38K
Currency in USD

Vivos Therapeutics Earnings and Revenue History